Isbn: 9786630162813 - microrna diagnostics in kidney disease: innovations and challenges: microrna-based biomarkers in chronic kidney disease: from molecular mechanisms to clinical applications (9 risultati)

Perfeziona la tua ricerca

  • Libri (9)

  • Nuovo (9)

a

Fascia di prezzo personalizzata (EUR)

a

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing, 2026

    6630162811 / 9786630162813

    • Brossura

    Da: PBShop.store US, Wood Dale, IL, U.S.A.PBShop.store US

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 60,30

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: Più di 20 disponibili

    PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

  • Lingua: Inglese

    Editore: LAP Lambert Academic Publishing, 2026

    6630162811 / 9786630162813

    • Brossura

    Da: California Books, Miami, FL, U.S.A.California Books

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 60,40

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: Più di 20 disponibili

    Condizione: New.

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing, 2026

    6630162811 / 9786630162813

    • Brossura

    Da: PBShop.store UK, Fairford, GLOS, Regno UnitoPBShop.store UK

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 58,49

    EUR 3,87 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: Più di 20 disponibili

    PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

  • Lingua: Inglese

    Editore: LAP Lambert Academic Publishing, 2026

    6630162811 / 9786630162813

    • Brossura
    • Print on Demand

    Da: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 60,29

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: 1 disponibile

    Paperback. Condizione: new. Paperback. Chronic kidney disease (CKD) poses a substantial global health issue, impacting over 850 million people worldwide. Current clinical biomarkers lack sufficient sensitivity to identify early renal injury. Small non-coding RNAs (ncRNAs) have gained increasing attention as promising biomarkers for the early diagnosis and therapeutic targeting of CKD. MicroRNAs are short ncRNA molecules that modulate gene expression. Owing to their remarkable stability in biological fluids, miRNAs can be reliably detected and quantified, highlighting their potential as prognostic and diagnostic biomarkers and as targets for therapy. Aberrant miRNA expression has been implicated as a critical contributor to the initiation and progression of numerous complex human disorders, including renal diseases. Accumulating evidence indicates that miRNAs may serve as viable targets for creating new treatment approaches for CKD. Accordingly, this book shows the current knowledge regarding the significance of miRNAs in the early diagnosis and intervention of CKD, also addressing key challenges and future directions in the development of miRNA-based therapeutics for CKD treatment. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing Jun 2026, 2026

    6630162811 / 9786630162813

    • Brossura
    • Print on Demand

    Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 48,90

    EUR 23,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 2 disponibili

    Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 64 pp. Englisch.

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing, 2026

    6630162811 / 9786630162813

    • Brossura
    • Print on Demand

    Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 49,49

    EUR 35,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 2 disponibili

    Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Chronic kidney disease (CKD) poses a substantial global health issue, impacting over 850 million people worldwide. Current clinical biomarkers lack sufficient sensitivity to identify early renal injury. Small non-coding RNAs (ncRNAs) have gained increasing attention as promising biomarkers for the early diagnosis and therapeutic targeting of CKD. MicroRNAs are short ncRNA molecules that modulate gene expression. Owing to their remarkable stability in biological fluids, miRNAs can be reliably detected and quantified, highlighting their potential as prognostic and diagnostic biomarkers and as targets for therapy. Aberrant miRNA expression has been implicated as a critical contributor to the initiation and progression of numerous complex human disorders, including renal diseases. Accumulating evidence indicates that miRNAs may serve as viable targets for creating new treatment approaches for CKD. Accordingly, this book shows the current knowledge regarding the significance of miRNAs in the early diagnosis and intervention of CKD, also addressing key challenges and future directions in the development of miRNA-based therapeutics for CKD treatment. …

  • Lingua: Inglese

    Editore: LAP Lambert Academic Publishing, 2026

    6630162811 / 9786630162813

    • Brossura
    • Print on Demand

    Da: CitiRetail, Stevenage, Regno UnitoCitiRetail

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 63,61

    EUR 43,54 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: 1 disponibile

    Paperback. Condizione: new. Paperback. Chronic kidney disease (CKD) poses a substantial global health issue, impacting over 850 million people worldwide. Current clinical biomarkers lack sufficient sensitivity to identify early renal injury. Small non-coding RNAs (ncRNAs) have gained increasing attention as promising biomarkers for the early diagnosis and therapeutic targeting of CKD. MicroRNAs are short ncRNA molecules that modulate gene expression. Owing to their remarkable stability in biological fluids, miRNAs can be reliably detected and quantified, highlighting their potential as prognostic and diagnostic biomarkers and as targets for therapy. Aberrant miRNA expression has been implicated as a critical contributor to the initiation and progression of numerous complex human disorders, including renal diseases. Accumulating evidence indicates that miRNAs may serve as viable targets for creating new treatment approaches for CKD. Accordingly, this book shows the current knowledge regarding the significance of miRNAs in the early diagnosis and intervention of CKD, also addressing key challenges and future directions in the development of miRNA-based therapeutics for CKD treatment. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing Jun 2026, 2026

    6630162811 / 9786630162813

    • Brossura
    • Print on Demand

    Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 48,90

    EUR 60,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibile

    Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Chronic kidney disease (CKD) poses a substantial global health issue, impacting over 850 million people worldwide. Current clinical biomarkers lack sufficient sensitivity to identify early renal injury. Small non-coding RNAs (ncRNAs) have gained increasing attention as promising biomarkers for the early diagnosis and therapeutic targeting of CKD. MicroRNAs are short ncRNA molecules that modulate gene expression. Owing to their remarkable stability in biological fluids, miRNAs can be reliably detected and quantified, highlighting their potential as prognostic and diagnostic biomarkers and as targets for therapy. Aberrant miRNA expression has been implicated as a critical contributor to the initiation and progression of numerous complex human disorders, including renal diseases. Accumulating evidence indicates that miRNAs may serve as viable targets for creating new treatment approaches for CKD. Accordingly, this book shows the current knowledge regarding the significance of miRNAs in the early diagnosis and intervention of CKD, also addressing key challenges and future directions in the development of miRNA-based therapeutics for CKD treatment. 64 pp. Englisch. …

  • Lingua: Inglese

    Editore: LAP LAMBERT Academic Publishing, 2026

    6630162811 / 9786630162813

    • Brossura
    • Print on Demand

    Da: preigu, Osnabrück, Germaniapreigu

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 42,55

    EUR 70,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 5 disponibili

    Taschenbuch. Condizione: Neu. MicroRNA Diagnostics in Kidney Disease: Innovations and Challenges | MicroRNA-Based Biomarkers in Chronic Kidney Disease: From Molecular Mechanisms to Clinical Applications | Weaam Gouda | Taschenbuch | Englisch | 2026 | LAP LAMBERT Academic Publishing | EAN 9786630162813 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand.…